Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mydent International is not a drug or biotech platform company; it is a well-established manufacturer of dental infection control and disposable products, with a global reach. Through its DEFEND brand, it offers a large portfolio of infection control and dental supply products, serving more than 45 countries. Its product line, sold primarily under the DEFEND brand, includes face masks, disinfectants, wipes, surface barriers, and antimicrobial garments. It has had an innovative role in infection control within dental and healthcare settings, but does not operate drug/device clinical programs and does not focus on pharmaceutical or therapeutic research. It does not operate in therapeutic drug or device development but focuses on manufacturing and supplying products for infection control, prevention, and routine dental practice use. In January 2018, the company was acquired by Young Innovations, which continues to operate the DEFEND brand and portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mydent International.